SANOFI-AVENTIS DEUTSCHLAND GMBH
- Country
- Germany
- Type
- Beneficiary
- Website
- www.sanofi.com
- Grants received
- 36
Funding record
- 36 grants on record
- €3,007,443.33 awarded in total
- 2009–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
21 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
- NOVO NORDISK A/S
- ASTRAZENECA AB
- GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
- BAYER AKTIENGESELLSCHAFT
- STICHTING RADBOUD UNIVERSITEIT
- ELI LILLY AND COMPANY LTD
Calls from this organisation
No published calls from this organisation.
Grants received
- Development of Chitosan-based Immobilized Catalysts for H/D Exchange in Continuous Flow Systems
- Photocatalytic Industrial Applications
- Photocatalytic Industrial Applications
- Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases
- Macrocycles for Drug Discovery
- Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing
- Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models
- Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research
- European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception
- Isotopic Labeling of Biotherapeutics
- Advancing Reaction Platforms for Drug Discovery
- Real World Handling of Protein Drugs - Exploration, Evaluation and Education
- Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA
- Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
- Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.